Vanguard Global Advisers’s SpyGlass Pharma SGP Stock Holding History
Bought
Maintained
Sold
Other funds holding SGP
Vanguard Global Advisers's SGP Position: Q3 2026 in Review
Vanguard Global Advisers reduced its SpyGlass Pharma (SGP) stake by 37% in Q3 2026, selling an estimated $42.3K and leaving 2,909 shares worth $75.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2900.
Vanguard Global Advisers first reported a position in SGP in Q1 2026 and has held it in 3 quarters since. The position peaked at $128K in Q1 2026. 70 funds tracked by Wall St. Rank hold SGP as of Q3 2026.
- Vanguard Global Advisers held 2,909 shares of SpyGlass Pharma worth $75.6K as of Q3 2026.
- Vanguard Global Advisers sold 1,718 SpyGlass Pharma shares in Q3 2026, an estimated $42.3K.
- SpyGlass Pharma made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2900 holding.
- Vanguard Global Advisers first reported a position in SpyGlass Pharma in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's SpyGlass Pharma position peaked at $128K in Q1 2026.
- 70 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.